185 related articles for article (PubMed ID: 11477113)
1. Fas ligand upregulation is an early event in colonic carcinogenesis.
Bennett MW; O'Connell J; Houston A; Kelly J; O'Sullivan GC; Collins JK; Shanahan F
J Clin Pathol; 2001 Aug; 54(8):598-604. PubMed ID: 11477113
[TBL] [Abstract][Full Text] [Related]
2. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
3. [The evaluation of Fas/Fas ligand system in renal cell carcinoma--the effect of preoperative interferon-alpha therapy].
Sejima T; Miyagawa I
Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):826-32. PubMed ID: 10565161
[TBL] [Abstract][Full Text] [Related]
4. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
[TBL] [Abstract][Full Text] [Related]
5. Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover.
Bennett MW; O'Connell J; O'Sullivan GC; Roche D; Brady C; Collins JK; Shanahan F
Dis Esophagus; 1999; 12(2):90-8. PubMed ID: 10466040
[TBL] [Abstract][Full Text] [Related]
6. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon.
Flohil CC; Janssen PA; Bosman FT
J Pathol; 1996 Apr; 178(4):393-7. PubMed ID: 8691316
[TBL] [Abstract][Full Text] [Related]
7. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
[TBL] [Abstract][Full Text] [Related]
9. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.
Kitagawa M; Yamaguchi S; Takahashi M; Tanizawa T; Hirokawa K; Kamiyama R
Leukemia; 1998 Apr; 12(4):486-92. PubMed ID: 9557605
[TBL] [Abstract][Full Text] [Related]
10. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
11. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.
Sträter J; Wellisch I; Riedl S; Walczak H; Koretz K; Tandara A; Krammer PH; Möller P
Gastroenterology; 1997 Jul; 113(1):160-7. PubMed ID: 9207274
[TBL] [Abstract][Full Text] [Related]
12. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.
Shiraki K; Tsuji N; Shioda T; Isselbacher KJ; Takahashi H
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6420-5. PubMed ID: 9177233
[TBL] [Abstract][Full Text] [Related]
13. Transitional cell carcinoma expresses high levels of Fas ligand in vivo.
Lee SH; Lee JY; Park WS; Kim SY; Jang JJ; Yoo NJ
BJU Int; 1999 Apr; 83(6):698-702. PubMed ID: 10233582
[TBL] [Abstract][Full Text] [Related]
14. Thymineless death in colon carcinoma cells is mediated via fas signaling.
Houghton JA; Harwood FG; Tillman DM
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8144-9. PubMed ID: 9223329
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel.
Risio M; Coverlizza S; Ferrari A; Candelaresi GL; Rossini FP
Gastroenterology; 1988 Apr; 94(4):899-906. PubMed ID: 3345890
[TBL] [Abstract][Full Text] [Related]
16. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
Ho SB; Ewing SL; Montgomery CK; Kim YS
Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
[TBL] [Abstract][Full Text] [Related]
17. Fas and Fas ligand expression in cystic fibrosis airway epithelium.
Durieu I; Amsellem C; Paulin C; Chambe MT; Bienvenu J; Bellon G; Pacheco Y
Thorax; 1999 Dec; 54(12):1093-8. PubMed ID: 10567629
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling.
Moss SF; Scholes JV; Holt PR
Dig Dis Sci; 1996 Nov; 41(11):2238-47. PubMed ID: 8943979
[TBL] [Abstract][Full Text] [Related]
19. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis.
Chen Q; Samaranayake LP; Zhen X; Luo G; Nie M; Li B
Oral Oncol; 1999 Nov; 35(6):548-53. PubMed ID: 10705088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
